These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9780508)

  • 1. [The clinical value of DNA ploidy in ovarian cancer].
    Obrebowska A; Spaczyński M
    Ginekol Pol; 1997 Oct; 68(10):478-82. PubMed ID: 9780508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
    Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy.
    Zangwill BC; Balsara G; Dunton C; Varello M; Rebane BA; Hernandez E; Atkinson BF
    Cancer; 1993 Apr; 71(7):2261-7. PubMed ID: 8453547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy as a prognostic factor in patients with ovarian carcinoma.
    Pietrzak K; Olszewski W
    Pol J Pathol; 1998; 49(3):141-4. PubMed ID: 9810171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ploidy analysis of epithelial ovarian cancers using image cytometry.
    Berchuck A; Boente MP; Kerns BJ; Kinney RB; Soper JT; Clarke-Pearson DL; Bast RC; Bacus SS
    Gynecol Oncol; 1992 Jan; 44(1):61-5. PubMed ID: 1370427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival and DNA ploidy in advanced epithelial ovarian cancer.
    Resnik E; Trujillo YP; Taxy JB
    J Surg Oncol; 1997 Apr; 64(4):299-303. PubMed ID: 9142186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 mutation site may be linked with nuclear DNA ploidy in BRCA1-mutated ovarian carcinomas.
    Aghmesheh M; Saxena A; Niknam F
    Asia Pac J Clin Oncol; 2015 Jun; 11(2):135-41. PubMed ID: 25428229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow and image cytometric DNA ploidy, including 5c exceeding cells, of serous borderline malignant ovarian tumors. Correlation with clinicopathologic characteristics.
    Flezar MS; But I; Kavalar R; Us-Krasovec M
    Anal Quant Cytol Histol; 2003 Jun; 25(3):139-45. PubMed ID: 12882085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy analysis of borderline epithelial ovarian tumours.
    Lodhi S; Najam S; Pervez S
    J Pak Med Assoc; 2000 Oct; 50(10):349-51. PubMed ID: 11109755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy analysis by laser scanning cytometry (LSC) in colorectal cancers and comparison with flow cytometry.
    Sasaki K; Kurose A; Miura Y; Sato T; Ikeda E
    Cytometry; 1996 Feb; 23(2):106-9. PubMed ID: 8742168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of cell DNA content in early-stage ovarian cancer (FIGO stages I and II/A) by means of automatic image cytometry.
    Wagner TM; Adler A; Sevelda P; Assmann I; Knepflé CF; Czerwenka K; Heinzl H; Ploem-Zaaijer JJ
    Int J Cancer; 1994 Jan; 56(2):167-72. PubMed ID: 8314296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma.
    Zanetta GM; Keeney GL; Kimlinger TK; Katzmann JA; Podratz KC
    Gynecol Oncol; 1996 Feb; 60(2):213-6. PubMed ID: 8631540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DNA quantification by flow cytometry in ovarian tumors.
    Kim YT; Zhao M; Kim SH; Lee CS; Kim JH; Kim JW
    Int J Gynaecol Obstet; 2005 Mar; 88(3):286-91. PubMed ID: 15733883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
    Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
    Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA ploidy in epithelial ovarian cancer--an independent prognostic factor].
    Tropé CG; Abeler V; Baekelandt M; Kaern J
    Tidsskr Nor Laegeforen; 2000 Jan; 120(1):43-9. PubMed ID: 10815478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of DNA flow cytometry in borderline malignant ovarian tumors.
    Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM
    Cancer; 1996 Aug; 78(4):794-802. PubMed ID: 8756374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.